Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
36514740 | 0 | Mavrakanas TA, Charytan DM. Apixaban versus No Anticoagulation by P2Y12 Inhibitor Prescription Status in Dialysis Patients with Atrial Fibrillation. Kidney360. 2022 Aug 1;3(10):1769-1771. doi: 10.34067/KID.0003002022. eCollection 2022 Oct 27. | |
35470213 | 0 | Mavrakanas TA. Treatment Options for Venous Thromboembolism in Patients Receiving Dialysis. Clin J Am Soc Nephrol. 2022 Apr 25. pii: CJN.03410322. doi: 10.2215/CJN.03410322. | |
35378030 | 0 | Mavrakanas TA. Should Oral Anticoagulation Be Used in ESKD Patients on Hemodialysis with Atrial Fibrillation?: COMMENTARY. Kidney360. 2021 Apr 9;2(9):1412-1414. doi: 10.34067/KID.0001372021. eCollection 2021 Sep 30. | |
33470571 | 0 | Barrelet I, Mavrakanas T, Carballo S. [Oral anticoagulation in chronic kidney disease]. Rev Med Suisse. 2021 Jan 20;17(722):142-145. | |
32740218 | 0 | Mavrakanas TA, Charytan DM, Winkelmayer WC. Direct oral anticoagulants in chronic kidney disease: an update. Curr Opin Nephrol Hypertens. 2020 Sep;29(5):489-496. doi: 10.1097/MNH.0000000000000634. | |
32444398 | 0 | Mavrakanas TA, Garlo K, Charytan DM. Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation. Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1146-1154. doi: 10.2215/CJN.11650919. Epub 2020 May 22. | |
32333946 | 0 | Ashley J, McArthur E, Bota S, et al. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants. Am J Kidney Dis. 2020 Sep;76(3):311-320. doi: 10.1053/j.ajkd.2020.02.446. Epub 2020 Apr 22. | |
29731031 | 0 | Mavrakanas TA, Sood MM. Direct Factor Xa Inhibitors for Long-term Stroke Prevention in Atrial Fibrillation: Could the Lower Dose Fit All? Can J Cardiol. 2018 May;34(5):690.e15. doi: 10.1016/j.cjca.2018.02.003. Epub 2018 Feb 7. | |
26507303 | 0 | Gariani K, Mavrakanas T, Combescure C, et al. Is diabetes mellitus a risk factor for venous thromboembolism? A systematic review and meta-analysis of case-control and cohort studies. Eur J Intern Med. 2016 Mar;28:52-8. doi: 10.1016/j.ejim.2015.10.001. Epub 2015 Oct 23. | |
25658756 | 0 | Mavrakanas TA, Samer C, Fontana P, et al. Direct oral anticoagulants: efficacy and safety in patient subgroups. Swiss Med Wkly. 2015 Feb 6;145:w14081. doi: 10.4414/smw.2015.14081. eCollection 2015. |